GSK comes under fire for chimp-derivative vaccine test

09 Jul 2019

However, medical professionals say the vaccine could save many lives if it is effective. The vaccine is for the paediatric respiratory syncytial virus (RSV), which is highly infectious and to which children of a young age are particularly vulnerable.

Rincert Moremi, the spokesperson for the Department of Agriculture, Forestry and Fisheries - which is responsible for public participation related to GMOs in South Africa - said this is the first application for a GMO-vaccine that it has received. Among the countries for which GSK is still awaiting permission are South Africa, Brazil, Australia, Argentina and Mexico.